Cynthia Kay Wilkett, DO in Jenks, OK - General Practice

Cynthia Kay Wilkett, DO is a General Practice physician based in Jenks, Oklahoma. Cynthia Kay Wilkett is licensed to practice in Oklahoma (license number 4586) and her current practice location is 3412 W 114th St S Ste 101, Jenks, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (918) 209-7214.

NPI number for Cynthia Kay Wilkett is 1023291457 and her current mailing address is 3412 W 114th St S Ste 101, Jenks, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023291457.

Contact Information

	Cynthia Kay Wilkett, DO
	3412 W 114th St S Ste 101, Jenks, OK 74037-6913
	(918) 209-7214
	Not Available

Physician's Profile

Full Name	Cynthia Kay Wilkett
Gender	Female
Speciality	General Practice
Location	3412 W 114th St S Ste 101, Jenks, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023291457
Provider Enumeration Date: 12/07/2007
Last Update Date: 04/12/2023

Medical Identifiers

Medical identifiers for Cynthia Kay Wilkett such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023291457	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	4586 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cynthia Kay Wilkett is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Cynthia Kay Wilkett, DO 3412 W 114th St S Ste 101, Jenks, OK 74037-6913 Ph: (918) 209-7214	Cynthia Kay Wilkett, DO 3412 W 114th St S Ste 101, Jenks, OK 74037-6913 Ph: (918) 209-7214

News Archive

Valeant Pharmaceuticals partners with NCADV to raise awareness of domestic violence

Valeant Pharmaceuticals International, Inc.announced a partnership with the National Coalition Against Domestic Violence to help raise awareness of domestic violence. As part of the new domestic violence initiative, Valeant has pledged to donate a portion of sales from all Medicis and Obagi products to the NCADV in support of its initiatives.

Regular practice of Transcendental Meditation benefits active-duty service members

Regular practice of Transcendental Meditation enables some active duty service members battling post-traumatic stress disorder to reduce or even eliminate their psychotropic medication and get better control of their often-debilitating symptoms, researchers report in the journal Military Medicine.

Bristol-Myers Squibb collaborates with Isis Pharmaceuticals

Bristol-Myers Squibb Company and Isis Pharmaceuticals have announced a collaboration to discover, develop and commercialize novel antisense drugs targeting proprotein convertase subtilisin kexin 9 (PCSK9) for the prevention and treatment of cardiovascular disease.

HRQoL benefit of alternative sunitinib dosing schedule in RCC patients

Patients with metastatic renal cell carcinoma reported a marked improvement in their health-related quality of life when given sunitinib on a 2 weeks on and 1 week off schedule compared with a 4 weeks on and 2 weeks off regimen, a Japanese study finds.

Cynthia Kay Wilkett, DO - General Practice in Jenks, OK